Overview

Detailed Summary

Walpar Nutritions Limited is engaged in the manufacturing, marketing, and trading of pharmaceuticals, nutraceuticals, herbal, and Ayurvedic products both online and offline.
The company evolved from a partnership firm into a public limited company with roots dating back to 2009, emphasizing its strong foundation in the nutraceutical domain.
Significant growth was marked by international market engagement, where Walpar expanded its footprint by exporting to countries like Nigeria, Vietnam, and Bangladesh.
The company has strengthened its manufacturing capabilities, especially in producing custom nutrition solutions, highlighting its adaptability to market demands.
Its diverse range of licenses, including FSSAI and AYUSH, enable it to manufacture a wide array of health-focused products.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 23 Cr
Volatility: Moderate Risk
P/E Ratio: 9.3
Industry P/E: 34.3
PEG Ratio: 0.1
P/B Ratio: 1.2
52W High: 51.80
52W Low: 21.25

Sales CAGR

1Y: 14.78%
3Y: 31.01%
5Y: 29.20%
10Y: —

Profit CAGR

1Y: 43.59%
3Y: 59.38%
5Y: 69.27%
10Y: —

ROE

TTM: 13.09%
3Y: 7.81%
5Y: 6.61%
10Y: —

ROCE

TTM: 13.74%
3Y: 12.33%
5Y: 10.17%
10Y: —

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
VENMAX		20.00	23 Cr	115.85	1.64	0.00	1.76	1.92	1.23
ISHITADR		74.70	22 Cr	28.77	1.94	0.00	6.73	9.78	6.19
PARMAX		59.32	22 Cr	-5.35	0.00	0.00	67.65	-85.76	-14.80
CHECKPOINT		40.00	22 Cr	14.58	0.94	0.00	6.49	7.62	0.44
WALPAR		23.20	22 Cr	8.82	1.15	0.00	13.09	13.74	4.84
CHCL		8.26	21 Cr	-0.89	2.42	0.00	-117.84	-25.84	-37.84
MONOPHARMA		11.65	21 Cr	24.80	0.66	0.00	2.67	6.38	0.70
Median: 7 Co.	—	23.20	22 Cr	14.58	1.15	0.00	6.49	6.38	0.70

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Half Yearly Results (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Sales	14	13	17	19	31	31	33	39	36	42
Expenses	13	12	16	16	29	29	30	36	34	39
Interest	0.25	0.24	0.44	0.36	0.33	0.34	0.26	0.03	0.30	0.50
Operating Profit	0.50	0.51	0.99	2.50	1.99	2.76	2.64	3.09	2.94	3.72
OPM %	3.58	3.99	5.99	13.43	6.39	8.80	8.12	7.87	8.06	8.79
Other Income	0.04	-0.02	0.05	0.27	0.06	0.16	0.31	-0.04	0.13	0.13
Depreciation	0.13	0.15	0.84	1.07	0.92	0.89	0.88	0.94	1.00	1.02
Profit Before Tax	0.17	0.11	-0.23	1.35	0.80	1.69	1.81	2.07	1.77	2.33
Tax %	29.41	-118.18	-39.13	15.56	18.75	23.08	22.10	32.85	15.25	27.04
Net Profit	0.12	0.24	-0.33	1.14	0.65	1.30	1.41	1.39	1.50	1.70
EPS in Rs	—	—	—	—	—	—	—	—	—	—

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	6.07	27	35	63	—
Expenses	5.61	26	32	58	0.00
Operating Profit	0.46	1.01	3.50	4.75	0.00
OPM %	7.52	3.78	9.95	7.60	—
Other Income	0.00	0.04	0.34	0.22	0.00
Interest	0.18	0.48	0.79	0.67	—
Depreciation	0.12	0.28	1.91	1.81	—
Profit Before Tax	0.16	0.27	1.11	2.49	—
Tax %	8.14	-30.19	27.12	21.97	—
Net Profit	0.15	0.36	0.81	1.95	—
EPS in Rs	—	—	—	—	—
Dividend Payout %	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	3.34	4.54	4.54	4.70	—
Reserves	1.44	6.45	7.17	9.49	—
Borrowings	7.49	7.25	10	8.30	0.00
Other Liabilities	5.73	9.84	12	15	0.00
Total Liabilities	18	28	34	37	—
Fixed Assets	1.70	2.01	10	10	0.00
CWIP	1.22	4.48	0.02	0.02	0.00
Investments	0.00	0.49	0.02	1.88	0.00
Other Assets	15	21	24	25	0.00
Total Assets	18	28	34	37	—

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity	-0.31	-1.08	1.10	5.35
Cash from Investing Activity	-2.02	-6.14	-3.44	-3.61
Cash from Financing Activity	2.95	6.71	2.42	-1.77
Net Cash Flow	0.62	-0.51	0.07	-0.03

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jul 2021	Sep 2021	Mar 2022	Sep 2022	Mar 2023	May 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Promoters	71.02%	71.02%	71.02%	70.58%	70.54%	71.46%	71.46%	71.23%	68.44%	68.52%	68.61%	68.82%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	28.98%	28.98%	28.98%	29.42%	29.46%	28.54%	28.54%	28.77%	31.56%	31.48%	31.39%	31.18%
Total Shareholders	481	496	460	291	270	258	233	226	335	333	345	327

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Walpar Nutritions Ltd

Walpar Nutritions Ltd (WALPAR) is currently trading at 24.35 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Walpar Nutritions Limited is engaged in the manufacturing, marketing, and trading of pharmaceuticals, nutraceuticals, herbal, and Ayurvedic products both online and offline. The company evolved from a partnership firm into a public limited company with roots dating back to 2009, emphasizing its strong foundation in the nutraceutical domain. Significant growth was marked by international market engagement, where Walpar expanded its footprint by exporting to countries like Nigeria, Vietnam, and Bangladesh. The company has strengthened its manufacturing capabilities, especially in producing custom nutrition solutions, highlighting its adaptability to market demands. Its diverse range of licenses, including FSSAI and AYUSH, enable it to manufacture a wide array of health-focused products.

Over the past 52 weeks, Walpar Nutritions Ltd has traded between a low of ₹21.25 and a high of ₹51.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Walpar Nutritions Ltd has a market capitalization of approximately 21.79. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Walpar Nutritions Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 8.82 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 21.79 Cr, Walpar Nutritions Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Walpar Nutritions Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Walpar Nutritions Ltd is 8.82. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Walpar Nutritions Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Consolidated Half Yearly Results (in ₹ Crores)

Consolidated Profit Loss (in ₹ Crores)

Consolidated Balance Sheet (in ₹ Crores)

Consolidated Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock more with professional

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Walpar Nutritions Ltd

What is Walpar Nutritions Ltd share price today?

What does Walpar Nutritions Ltd do?

What is the 52-week high and low of Walpar Nutritions Ltd?

What is the market capitalization of Walpar Nutritions Ltd?

Should I consider investing in Walpar Nutritions Ltd stock?

Is Walpar Nutritions Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Walpar Nutritions Ltd belong to and why does it matter?

What is the PE ratio of Walpar Nutritions Ltd?

Investor’s Suite

Market Explorer

Market Pulse

Deep Dive

Utility

Company

Technicals

Forecasts

Projection

Frequently Asked Questions about Walpar Nutritions Ltd

What is Walpar Nutritions Ltd share price today?

What does Walpar Nutritions Ltd do?

What is the 52-week high and low of Walpar Nutritions Ltd?

What is the market capitalization of Walpar Nutritions Ltd?

Should I consider investing in Walpar Nutritions Ltd stock?

Is Walpar Nutritions Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Walpar Nutritions Ltd belong to and why does it matter?

What is the PE ratio of Walpar Nutritions Ltd?

Announcements

Oscillators

Bullish

Overall

Bearish

Moving Averages

Bearish

Overall

Bearish

Peers

Price Chart Comparison

Overview

Financial Ratios

Investment Checklist